Narrowband-UVB treatment for psoriasis is highly economical and causes significant savings in cost for topical treatments.

CONCLUSIONS: NB-UVB is a low-cost treatment; cost figures currently used in health technology appraisals are an overestimate based on the data presented here. Creating or extending access to NB-UVB is likely to offer additional savings by delaying or avoiding costly third line treatments for many patients. This article is protected by copyright. All rights reserved.
PMID: 29901862 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - June 14, 2018 Category: Dermatology Authors: Boswell K, Cameron H, West J, Fleming C, Ibbotson S, Dawe R, Foerster J Tags: Br J Dermatol Source Type: research